Uninterrupted ibrutinib with CAR T could improve CLL outcomesJanuary 25, 2019Leukemia, Myelodysplasia, TransplantationImmunotherapyImmuno-oncology
Dual BRAF, MEK inhibition proves highly active in biliary tract cancerJanuary 24, 2019GastroenterologyGastrointestinal Cancer
Are single agents better than chemo for relapsed/refractory PTCL?January 24, 2019Lymphoma & Plasma Cell Disorders
mRECIST response to kinase inhibitors predicts survival in HCCJanuary 24, 2019GastroenterologyGastrointestinal Cancer
Trump zeroes in on surprise medical bills in White House chat with patients, expertsJanuary 24, 2019Practice Management
Avelumab active in recurrent or refractory ovarian cancerJanuary 24, 2019Gynecologic CancerImmuno-oncology
Gametes for back pain, Alice in Wonderland syndrome, and liver-saving beerJanuary 23, 2019LOTMEPractice Management
Pembrolizumab bests chemo in PD-L1-positive esophageal cancerJanuary 23, 2019GastroenterologyImmuno-oncologyGastrointestinal Cancer
